Xeomin receives FDA approval for treatment of cervical dystonia
Links shared publicly online about this topic.
- 977total visits
Xeomin receives FDA approval for treatment of cervical dystonia
View full resource at news-medical.net
Tags: Botulism, Spasmodic Torticollis, Parkinson's Disease, Disease and Condition, Drug, Pharma, FDA
Most Recently Shared on August 16, 2010 at 5:18 pm By:
Xeomin, a new competitor to BOTOX Cosmetic is approved for medical use by the FDA- http://bit.ly/dmUQPu
Also Shared By:
Pharmacy Europe - FDA approves Xeomin for the treatment of cervical dystonia and blepharospasm
pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on August 4, 2010 at 6:21 am By:
Drugs and Devices OW OW Health
FDA approves Xeomin for the treatment of cervical dystonia and blepharospasm: Merz Pharmaceuticals has announced t... http://bit.ly/aGazsY
FDA Approves Merz Pharmaceuticals' Xeomin® (IncobotulinumtoxinA) For The Treatment Of Cervical Dystonia And Blepharospasm
medicalnewstoday.com — “Merz Pharmaceuticals has announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 3:05 pm By:
MNT Neurology News Health News and Neurology
FDA Approves Merz Pharmaceuticals' Xeomin® (IncobotulinumtoxinA) For The Treatment Of Cervical Dystonia And Blepha... http://mnt.to/3GTG
FDA Approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
drugs.com — “Xeomin (incobotulinumtoxinA) is used to treat cervical dystonia and blepharospasm. Includes Xeomin side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2010 at 11:54 pm By:
FDA Approves Xeomin (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm - http://bit.ly/a4RGn1
Xeomin approved for cervical dystonia and blepharospasm - ONA
oncologynurseadvisor.com — “Merz Pharmaceuticals announced that the FDA has approved Xeomin (incobotulinumtoxinA) for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain in both botulinum toxin-nave and previously treated patients and blepharospasm in adults previously treated with onabotulinumtoxinA.” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 2, 2010 at 4:23 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Xeomin approved for cervical dystonia and blepharospasm http://goo.gl/fb/CKYJo
Xeomin approved for cervical dystonia and blepharospasm - MPR
empr.com — “Merz Pharmaceuticals announced that the FDA has approved Xeomin (incobotulinumtoxinA) for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain in both botulinum toxin-nave and previously treated patients and blepharospasm in adults previously treated with onabotulinumtoxinA.” View full resource at empr.com
Most Recently Shared on August 2, 2010 at 4:17 pm By:
MPR News: Xeomin approved for cervical dystonia and blepharospasm: Merz Pharmaceuticals announced that the FDA has... http://bit.ly/cEumpe
Advertisement
News-Medical.Net
@NewsMedical
Xeomin receives FDA approval for treatment of cervical dystonia: Merz Pharmaceuticals today announced that the Uni... http://bit.ly/9usAe8
1 year ago...